Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology

Journal of the American Academy of Dermatology
Rolf-Markus SzeimiesAgustín Alomar

Abstract

Increasing evidence suggests imiquimod may be a safe therapeutic option for the treatment of actinic keratosis (AK). The diagnosis and assessment of most AK lesions is made clinically, without histologic confirmation. A phase III, randomized, double-blind, parallel group, vehicle-controlled study evaluated the efficacy of imiquimod 5% cream compared with vehicle in the treatment of AK lesions on the face and balding scalp including pretreatment and posttreatment biopsy specimens. A total of 286 patients at 18 centers in 6 European countries with histologically confirmed AK were randomized to either imiquimod 5% cream or vehicle cream. Study cream was applied once per day, 3 days per week, for 16 weeks. Clearance of AK lesions was clinically and histologically assessed at an 8-week posttreatment visit. The complete clearance rate for the imiquimod group was 57.1% versus 2.2% for the vehicle group (P <.001). The partial clearance rate (> or =75% reduction in baseline lesions) for the imiquimod group was 72.1% versus 4.3% for the vehicle group (P <.001). The most common side effects were erythema, scabbing/crusting, and erosions/ulceration. For the imiquimod group the incidence of severe erythema, scabbing/crusting, or erosions/ul...Continue Reading

Associated Clinical Trials

Sep 5, 2013·Sol Beatriz Jiménez

References

Jun 1, 1997·The Australasian Journal of Dermatology·E Kocsard
May 29, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·Isabelle UhodaGérald E Piérard

❮ Previous
Next ❯

Citations

Apr 9, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·R-M SzeimiesH Bäcker
Dec 4, 2012·Dermatology and Therapy·Faisal R AliJohn T Lear
Jan 8, 2008·Oncogene·M P Schön, M Schön
Apr 14, 2010·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Bahar F Firoz, Leonard H Goldberg
Mar 20, 2013·BioMed Research International·Christina WlodekJohn T Lear
Jan 30, 2007·Journal of Translational Medicine·Abel TorresWoubalem Birmachu
Nov 1, 2013·Anais Brasileiros De Dermatologia·Luís Antônio Ribeiro Torezan, Cyro Festa-Neto
Jun 22, 2011·Clinical, Cosmetic and Investigational Dermatology·Caroline Caperton, Brian Berman
Dec 14, 2007·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Kathleen SmithHenry Skelton
Jul 6, 2005·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Peter K LeeJames H Lee
May 19, 2006·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Michelle A Pipitone, Hugh M Gloster
Mar 15, 2014·Dermatology and Therapy·Annabel DoddsStephen Shumack
Mar 25, 2006·The Journal of Investigative Dermatology·Gina HadleyRobert A Moore
Dec 20, 2005·The Journal of Dermatology·Saburo AnzaiSakuhei Fujiwara
May 31, 2007·The Australasian Journal of Dermatology·Cara HolmesAlvin H Chong
May 15, 2008·The British Journal of Dermatology·R-M SzeimiesT-C Meng
Jan 17, 2007·The British Journal of Dermatology·D de BerkerUNKNOWN British Association of Dermatologists Therapy Guidelines and Audit Subcommittee
Sep 24, 2008·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Constance HuykeChristoph Schempp
Apr 16, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·R A SchwartzA Ehrlich
Dec 23, 2006·International Journal of Dermatology·P A FantiC Varotti
Mar 1, 2006·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Constance HuykeChristoph M Schempp
May 8, 2013·The British Journal of Dermatology·R N WernerA Nast
Mar 21, 2012·Molecular Carcinogenesis·Maki YokogawaShigetoshi Sano
Aug 22, 2013·International Journal of Dermatology·John E Wolf, Darrell S Rigel
May 4, 2012·Journal of the American Academy of Nurse Practitioners·Christopher Englert, Brittney Hughes
Mar 13, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·B DrénoUNKNOWN AKTeam™
Feb 28, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Takashi KarashimaTaro Shuin
Aug 16, 2006·Journal of the American Academy of Dermatology·Matthew E FalagasGeorge Peppas
Jun 20, 2006·Journal of the American Academy of Dermatology·Ignacio Sanchez-CarpinteroMartin C Mihm
Nov 23, 2005·International Journal of Pharmaceutics·Ryan F DonnellyA David Woolfson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.